时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
15:30-15:38 | 论文发言 |
Long-term efficacy of microwave ablation for multifocal papillary thyroid microcarcinoma —— A Five-year follow-up study |
|
|||
15:38-15:46 | 论文发言 |
Early effect of Hashimoto's thyroiditis on ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma |
|
|||
15:46-15:54 | 论文发言 |
Deep Learning Model Based on Contrast-Enhanced Ultrasound for Predicting Early Recurrence After Thermal Ablation of Colorectal Cancer Liver Metastasis |
|
|||
15:54-16:02 | 论文发言 |
Microwave ablation for papillary thyroid microcarcinoma with ultrasound-detected capsule invasion: A multicenter prospective cohort study |
|
|||
16:02-16:10 | 论文发言 |
Subharmobnic scattering of Sonazoid microbubbles for evaluating tumor interstitial fluid pressure in mice |
|
|||
16:10-16:18 | 论文发言 |
Multi-omics Analysis reveals Intra-tumoral Changes Induced by Irreversible Electroporation on Pancreatic Ductal adenocarcinoma in mice |
|
|||
16:18-16:26 | 论文发言 |
Dual-Modal Radiomics Based on Grayscale Ultrasound and Dual-Energy Computed Tomography for Predicting Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Modified Support Vector Machine (SVM) Classifier |
|
|||
16:26-16:34 | 论文发言 |
Three-dimensional Shear Wave Elastography for Differentiating Benign from Malignant Thyroid Nodules in Comparison with Conventional Ultrasound and Two-Dimensional Shear Wave Elastography |
|
|||
16:34-16:42 | 论文发言 |
Early assessment of chemoradiotherapy response for locally advanced pancreatic ductal adenocarcinoma by dynamic contrast enhanced ultrasound |
|
|||
16:42-16:50 | 论文发言 |
Multimodal Ultrasound Fusion Network for Differentiating Between Benign and Malignant Renal Tumors |
|
|||
16:50-16:58 | 论文发言 |
Intrahepatic Nodules with Hyperenhanced Rim on the Sonazoid-CEUS Kupffer Phase Images are Responsive Markers of Anti-PD-1/PD-L1 Antibody Therapy for Hepatocellular Carcinoma |
|
|||
16:58-17:06 | 论文发言 |
Preoperative differentiation of combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma in at-risk patients based on contrast-enhanced ultrasound and contrast-enhanced computed tomography |
|